Search Results - Simon Goller

  • Showing 1 - 4 results of 4
Refine Results
  1. 1

    AXL is a novel ERK5/KLF4 target in MEK inhibitor-treated melanoma by Rupesh Paudel, Simon Goller, Stefanie Schwarz, Katharina Meder, Matthias Goebeler, Marc Schmidt

    Get full text
    Article


  2. 2

    Patient-Centered Chronic Wound Care Mobile Apps: Systematic Identification, Analysis, and Assessment by Tassilo Dege, Bernadette Glatzel, Vanessa Borst, Franziska Grän, Simon Goller, Caroline Glatzel, Matthias Goebeler, Astrid Schmieder

    Published in JMIR mHealth and uHealth (2024-03-01)
    Get full text
    Article


  3. 3

    MEK5/ERK5 inhibition sensitizes NRAS-mutant melanoma to MAPK-targeted therapy by preventing Cyclin D/CDK4-mediated G1/S progression by Rupesh Paudel, Simon Goller, Felix Deutzmann, Alina Gillitzer, Katharina Meder, Andrea Knorz, David Schrama, Matthias Goebeler, Marc Schmidt

    Published in Cell Death and Disease (2025-10-01)
    Get full text
    Article


  4. 4

    LncRNA SLNCR phenocopies the E2F1 DNA binding site to promote melanoma progression by Kushani Shah, Eleni Anastasakou, Leinal Sejour, Yufei Wang, Leon Wert-Lamas, Christopher Rauchet, Sabine Studer, Simon Goller, Robert J. Distel, Wayne Marasco, Lalith Perera, Ioannis S. Vlachos, Carl D. Novina

    Published in Cell Reports (2025-05-01)
    Get full text
    Article


Search Tools: